Smoking and secondhand smoke are important drivers of chronic respiratory disease, including chronic obstructive pulmonary disease (COPD). Shanghai implemented comprehensive smoke-free legislation intended to reduce tobacco exposure and related health harms. This study used an interrupted time series design to assess whether the legislation was associated with changes in COPD hospital admissions and mortality.
The primary objective reported by the authors was to evaluate short-term and longer-term impacts of the legislation on population-level COPD admissions and deaths among adults aged 35 years and older, using routinely collected health data from July 2013 through December 2019.
The analysis covered hospital admissions and deaths attributed to COPD between July 2013 and December 2019. The investigators applied an interrupted time series framework to estimate changes associated with the introduction of Shanghai’s smoke-free legislation. Models adjusted for demographic variables, weather, ambient PM2.5, and seasonality to reduce potential confounding by known drivers of respiratory morbidity and mortality.
Outcomes reported in the abstract included a total of 358,941 COPD hospital admissions and 56,824 COPD deaths over the study period. The authors also conducted subgroup analyses by age and performed sensitivity checks using age-standardized rates and alternative count models (Poisson and negative binomial) to assess robustness of findings.
In the overall population of adults aged ≥35 years, the study found no evidence of a statistically significant short-term reduction in COPD hospital admissions or mortality immediately following implementation of the smoke-free legislation. Although both admissions and mortality exhibited downward trends over the longer term, these overall changes did not reach statistical significance in the primary analyses reported.
The reported counts (358,941 admissions and 56,824 deaths) reflect the observed burden of COPD during the analyzed interval and formed the basis for the time-series estimates.
Subgroup analysis identified a modest but statistically significant long-term decline in hospital admissions among adults aged 35–64 years, with an estimated coefficient of β = -0.06 (P < .05) reported in the abstract. No statistically significant short-term mortality change was observed among adults aged ≥65 years.
Sensitivity analyses using age-standardized measures and alternative modelling approaches (Poisson and negative binomial) produced similar trends for admissions and broadly consistent patterns for long-term mortality, supporting the robustness of the primary admission results.
The study’s principal interpretation is that Shanghai’s comprehensive smoke-free legislation was not associated with a detectable short-term reduction in COPD hospital admissions or mortality among adults aged ≥35 years. However, observed long-term downward trends in both outcomes—most notably a statistically significant longer-term decrease in admissions among 35–64-year-olds—suggest that population health benefits may accrue gradually rather than immediately following policy enactment.
The absence of a marked short-term effect could reflect lag times between exposure reduction and measurable changes in COPD events, incomplete enforcement or coverage of the law, prevailing background exposure patterns (including outdoor and private settings), or the chronic nature of COPD where disease progression and event rates change slowly.
Based on reported findings, the authors recommend sustained implementation of stringent tobacco control measures and improvements in enforcement to amplify health benefits. Specific recommendations highlighted include broadening smoke-free areas (including attention to outdoor smoking), strengthening enforcement mechanisms, and integrating complementary interventions such as smoking cessation support to enhance long-term effectiveness.
These recommendations reflect the study conclusion that while some long-term declines were observed, the overall public health impact of the legislation to date appears limited and likely requires expanded and sustained policy and programmatic interventions to achieve larger reductions in COPD burden.
The abstract notes the interrupted time series design and multivariable adjustments used, and it reports sensitivity analyses that support the main admission findings. The authors concluded that the legislation was associated with long-term downward trends in COPD-related admissions and mortality but that the immediate impact was not detectable and the overall effect remained limited.
Details beyond the abstract—for example, specific implementation dates, enforcement metrics, granular age- or sex-stratified estimates beyond those reported, or full model specifications—were not reported in the source text provided here.
In sum, this population-level analysis provides empirical evidence that comprehensive smoke-free legislation in Shanghai was followed by gradual reductions in COPD outcomes over time, with modest benefits evident in some age subgroups, and underscores the need for continued policy strengthening, enforcement, and complementary public health measures to maximize long-term reductions in COPD morbidity and mortality.